.jpg)
.png)
All
The NLA has consistently held a determined focus on promoting the highest levels of education and professional development. We are defined by the quality of our outstanding leadership, members, partners and staff. As a result, we are continuously challenged to assess and refine our work in an... more
By Jennifer J Brown, PhD, Everyday Health Staff Writer Matt Ito, PharmD, is the president of the National Lipid Association for a very good reason. He has inherited a dangerously high cholesterol condition called familial hypercholesterolemia, or FH, which affects more than 600,000... more
The Journal of Clinical Lipidology announced on Monday its 2016 Impact Factor has risen to 5.812, up from 4.906 in 2015. Led by Editor-In-Chief W. Virgil Brown, M.D., the JCL has seen a steady growth in submissions and readership since first publishing in 2007. It now ranks 17th of 256 journals in... more
A cardioprotective eating pattern is a proven mainstay of therapy for both the treatment and prevention of atherosclerotic cardiovascular disease (ASCVD). Many controversial diets, foods and supplements have made their way into the media and into our kitchen with promises to improve cardiovascular... more
As a practicing preventive cardiologist since 2001 and clinical lipidologist since 2005, I am glad to see our organization taking a strong and clear position on the updated cholesterol treatment guidelines. NLA is the only national organization that is all about CVD prevention - nearly all articles... more
Omega 3 Fatty Acids in the Treatment of Dyslipidemia Lipid Luminations
This issue sponsored by the National Lipid Association Featuring: “Search for the Secondary Cause: Worth the Pause” and "Clinical Conundrum: The Estimated LDL-C Below 40 mg/dL" more
Special Education Session at the Orlando 2014 Annual Scientific Sessions: The National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia Friday, May 2 • 6:45 – 7:45 a.m. As you know, the American College of Cardiology and the American Heart... more
This issue sponsored by the Pacific Lipid Association Cardiovascular Risk and Dyslipidemia in Mexican-Americans Pharmacologic Treatment of Non-HDL-C and Goal Attainment
th, td { padding: 3px; } W. Virgil Brown, MD, FNLA This award is the highest honor conferred by the NLA, honoring outstanding contributions in the diagnosis and treatment of lipid disorders. The W. Virgil Brown Distinguished Achievement Award and Lectureship was... more